[The use of ranitidine in antineoplastic polychemotherapy].
The Author analyzes the ranitidine's role in course of antiblastic treatments. The drug, administrated the night orally at the dose of 300 mgr/pro die, improves the tolerance of antineoplastic drugs and determines less incidence of gastric injuries in oncologic patients.